BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright ©The Author(s) 2026.
World J Clin Oncol. Jan 24, 2026; 17(1): 113966
Published online Jan 24, 2026. doi: 10.5306/wjco.v17.i1.113966
Figure 1
Figure 1 Pathological results. A: Hematoxylin-eosin staining of the left femoral head section showing the pathological lesion; B-E: Histopathology of myeloid sarcoma with positive staining for CD42b (B), CD71 (C), Ki-67 (D), and myeloperoxidase (E); F: Reticular fiber staining in the bone marrow (magnification × 10).
Figure 2
Figure 2 18F-fluorodeoxyglucose positron emission tomography/and computed tomography showing multiple focal bone destructions, mainly in the left femoral head. A: Non-enhanced computed tomography (CT) image; B: Positron emission tomography (PET) image; C: Fused PET and CT images; D: PET maximal intensity projection image in the coronal plane.